Mutant KRAS upregulates the production of cytokines and chemokines, such as IL-6, CXCL8, and TGF-β, which recruit regulatory T-cells (Tregs), myeloid-derived suppressor cells (MDSCs), and tumor-associated macrophages (TAMs) to the TME. The gene discussed is KRAS; the disease is neoplasm.